JPRN-jRCT1032220559尚未招募Unknown
Exploratory analysis of liquid biopsy for the predictive factors associated with outcome of PD-1 Pathway Blockade in Multicenter Study - MRD-PD1 study
Ohe Yuichiro0 个研究点目标入组 100 人开始时间: 2023年1月7日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who meet the eligibility criteria of the most recent JCOG 1701 (to confirm the non-inferiority of survival of discontinuation of PD-1 pathway inhibitors versus their continuation in patients with advanced or recurrent non-small-cell lung cancer who have had no reccurence to PD-1 pathway inhibitors for 12 months or longer) protocol and who are not participating in JCOG 1701
- •Patients who have given their written consent to participate in this study
- •Patients who are able to provide tumor tissue samples necessary for the study
排除标准
- •Patients who do not meet the eligibility criteria in the most recent JCOG1701 protocol or are currently participating in JCOG1701
研究者
相似试验
招募中
不适用
Exploratory research of liquid biopsy for patients with cancercancerJPRN-UMIN000033269Cancer Precision Medicine Center Cancer Institute,800
已完成
不适用
Investigation on the usefulness of liquid biopsy for tumor-derived circulating DNA in patients with EGFR-mutant NSCLC during and after treatment with EGFR-TKIson-small cell Lung CancerJPRN-UMIN000023248PHRF122
招募中
Unknown
Validation process of liquid biopsy for solid tumorsCTRI/2023/03/050258Cancer Research and Statistic Foundation CRSF
进行中（未招募）
1 期
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code: 10025055Term: Lung cancer non-small cell stage IV Class: 10029104CTIS2024-511317-38-00Fundacion GECP33
进行中（未招募）
1 期
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864EUCTR2019-002369-36-ESFundación GECP30